US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist
  • 76.210
  • +0.560+0.74%
Close Feb 28 16:00 ET
  • 76.200
  • -0.010-0.01%
Post 20:01 ET
236.27BMarket Cap33.87P/E (TTM)

AstraZeneca Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
18.03%54.07B
23.84%14.89B
18.04%13.57B
13.33%12.94B
16.55%12.68B
3.29%45.81B
7.29%12.02B
4.64%11.49B
5.99%11.42B
-4.49%10.88B
Operating revenue
18.03%54.07B
23.84%14.89B
18.04%13.57B
13.33%12.94B
16.55%12.68B
3.29%45.81B
7.29%12.02B
4.64%11.49B
5.99%11.42B
-4.49%10.88B
Cost of revenue
23.45%10.21B
18.07%2.73B
47.06%3.08B
11.38%2.18B
16.43%2.22B
-33.27%8.27B
-20.41%2.31B
-29.75%2.1B
-34.62%1.96B
-45.74%1.91B
Gross profit
16.84%43.87B
25.22%12.17B
11.57%10.48B
13.74%10.76B
16.57%10.46B
17.47%37.54B
16.96%9.72B
17.46%9.4B
21.65%9.46B
13.90%8.97B
Operating expense
16.63%33.62B
19.43%10.13B
12.56%8.38B
14.41%8.01B
10.20%7.35B
5.00%28.82B
32.59%8.48B
10.19%7.44B
-3.23%7B
-4.79%6.67B
Selling and administrative expenses
10.99%20.22B
0.67%5.55B
7.28%5.29B
-1.09%5.06B
10.42%4.63B
1.32%18.22B
44.93%5.52B
11.95%4.93B
6.38%5.12B
-15.55%4.19B
-Selling and marketing expense
2.97%555M
-1.38%143M
12.40%145M
0.76%132M
0.75%135M
0.56%539M
-7.05%145M
2.38%129M
1.55%131M
7.20%134M
-General and administrative expense
11.23%19.67B
0.73%5.41B
7.15%5.14B
-1.14%4.93B
10.74%4.5B
1.35%17.68B
47.15%5.37B
12.23%4.8B
6.52%4.99B
-16.14%4.06B
Research and development costs
24.22%13.58B
52.20%4.68B
20.55%3.12B
12.79%3.01B
6.59%2.78B
12.02%10.94B
17.07%3.07B
5.13%2.58B
4.75%2.67B
22.41%2.61B
Other operating expenses
-26.22%121M
----
----
----
----
-18.00%164M
----
----
----
----
Operating profit
17.53%10.25B
64.99%2.04B
7.78%2.11B
11.81%2.75B
34.97%3.12B
93.31%8.72B
-35.39%1.23B
56.95%1.95B
355.66%2.46B
162.87%2.31B
Net non-operating interest income expense
-3.80%-1.34B
-8.31%-365M
5.84%-274M
6.54%-343M
-5.23%-302M
-3.12%-1.29B
-7.67%-337M
10.19%-291M
-25.26%-367M
10.03%-287M
Non-operating interest income
14.62%345M
-40.74%64M
81.19%183M
56.25%100M
42.31%111M
271.60%301M
248.39%108M
573.33%101M
255.56%64M
358.82%78M
Non-operating interest expense
5.85%1.68B
-3.60%429M
16.58%457M
2.78%443M
13.15%413M
19.47%1.59B
29.36%445M
15.63%392M
38.59%431M
8.63%365M
Other net income (expense)
Special income (charges)
53.12%-248M
----
----
----
--0
29.93%-529M
----
----
----
--241M
-Less：Restructuring and merger&acquisition
-50.00%260M
----
----
----
----
185.71%520M
----
----
----
----
-Less:Other special charges
-233.33%-12M
----
----
----
----
-98.43%9M
----
----
----
---241M
Income before tax
25.97%8.69B
85.73%1.67B
10.65%1.83B
14.80%2.4B
23.78%2.8B
175.85%6.9B
15.30%897M
79.18%1.65B
745.34%2.09B
309.04%2.26B
Income tax
75.91%1.65B
367.74%166M
44.16%395M
75.00%469M
35.37%620M
218.43%938M
50.00%-62M
138.06%274M
337.17%268M
177.58%458M
Net income
18.12%7.04B
56.41%1.5B
3.99%1.43B
5.93%1.93B
20.84%2.18B
81.02%5.96B
6.32%959M
-16.08%1.38B
405.56%1.82B
364.95%1.8B
Net income continuous Operations
18.12%7.04B
56.41%1.5B
3.99%1.43B
5.93%1.93B
20.84%2.18B
81.02%5.96B
6.32%959M
-16.08%1.38B
405.56%1.82B
364.95%1.8B
Minority interest income
0.00%6M
0
0.00%4M
-50.00%1M
0.00%1M
20.00%6M
-200.00%-1M
100.00%4M
2M
-50.00%1M
Net income attributable to the parent company
18.14%7.04B
56.25%1.5B
4.00%1.43B
6.00%1.93B
20.85%2.18B
81.11%5.96B
6.55%960M
-16.22%1.37B
405.00%1.82B
367.10%1.8B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
18.14%7.04B
56.25%1.5B
4.00%1.43B
6.00%1.93B
20.85%2.18B
81.11%5.96B
6.55%960M
-16.22%1.37B
405.00%1.82B
367.10%1.8B
Basic earnings per share
18.23%2.27
56.45%0.485
3.37%0.46
5.98%0.62
21.55%0.705
81.13%1.92
6.90%0.31
-16.04%0.445
408.70%0.585
364.00%0.58
Diluted earnings per share
18.11%2.25
54.84%0.48
3.41%0.455
5.98%0.62
20.69%0.7
80.57%1.905
6.90%0.31
-16.19%0.44
408.70%0.585
364.00%0.58
Dividend per share
2.41%1.485
0
7.53%0.5
0
0.00%0.985
0.00%1.45
0
0.00%0.465
0
0.00%0.985
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 18.03%54.07B23.84%14.89B18.04%13.57B13.33%12.94B16.55%12.68B3.29%45.81B7.29%12.02B4.64%11.49B5.99%11.42B-4.49%10.88B
Operating revenue 18.03%54.07B23.84%14.89B18.04%13.57B13.33%12.94B16.55%12.68B3.29%45.81B7.29%12.02B4.64%11.49B5.99%11.42B-4.49%10.88B
Cost of revenue 23.45%10.21B18.07%2.73B47.06%3.08B11.38%2.18B16.43%2.22B-33.27%8.27B-20.41%2.31B-29.75%2.1B-34.62%1.96B-45.74%1.91B
Gross profit 16.84%43.87B25.22%12.17B11.57%10.48B13.74%10.76B16.57%10.46B17.47%37.54B16.96%9.72B17.46%9.4B21.65%9.46B13.90%8.97B
Operating expense 16.63%33.62B19.43%10.13B12.56%8.38B14.41%8.01B10.20%7.35B5.00%28.82B32.59%8.48B10.19%7.44B-3.23%7B-4.79%6.67B
Selling and administrative expenses 10.99%20.22B0.67%5.55B7.28%5.29B-1.09%5.06B10.42%4.63B1.32%18.22B44.93%5.52B11.95%4.93B6.38%5.12B-15.55%4.19B
-Selling and marketing expense 2.97%555M-1.38%143M12.40%145M0.76%132M0.75%135M0.56%539M-7.05%145M2.38%129M1.55%131M7.20%134M
-General and administrative expense 11.23%19.67B0.73%5.41B7.15%5.14B-1.14%4.93B10.74%4.5B1.35%17.68B47.15%5.37B12.23%4.8B6.52%4.99B-16.14%4.06B
Research and development costs 24.22%13.58B52.20%4.68B20.55%3.12B12.79%3.01B6.59%2.78B12.02%10.94B17.07%3.07B5.13%2.58B4.75%2.67B22.41%2.61B
Other operating expenses -26.22%121M-----------------18.00%164M----------------
Operating profit 17.53%10.25B64.99%2.04B7.78%2.11B11.81%2.75B34.97%3.12B93.31%8.72B-35.39%1.23B56.95%1.95B355.66%2.46B162.87%2.31B
Net non-operating interest income expense -3.80%-1.34B-8.31%-365M5.84%-274M6.54%-343M-5.23%-302M-3.12%-1.29B-7.67%-337M10.19%-291M-25.26%-367M10.03%-287M
Non-operating interest income 14.62%345M-40.74%64M81.19%183M56.25%100M42.31%111M271.60%301M248.39%108M573.33%101M255.56%64M358.82%78M
Non-operating interest expense 5.85%1.68B-3.60%429M16.58%457M2.78%443M13.15%413M19.47%1.59B29.36%445M15.63%392M38.59%431M8.63%365M
Other net income (expense)
Special income (charges) 53.12%-248M--------------029.93%-529M--------------241M
-Less：Restructuring and merger&acquisition -50.00%260M----------------185.71%520M----------------
-Less:Other special charges -233.33%-12M-----------------98.43%9M---------------241M
Income before tax 25.97%8.69B85.73%1.67B10.65%1.83B14.80%2.4B23.78%2.8B175.85%6.9B15.30%897M79.18%1.65B745.34%2.09B309.04%2.26B
Income tax 75.91%1.65B367.74%166M44.16%395M75.00%469M35.37%620M218.43%938M50.00%-62M138.06%274M337.17%268M177.58%458M
Net income 18.12%7.04B56.41%1.5B3.99%1.43B5.93%1.93B20.84%2.18B81.02%5.96B6.32%959M-16.08%1.38B405.56%1.82B364.95%1.8B
Net income continuous Operations 18.12%7.04B56.41%1.5B3.99%1.43B5.93%1.93B20.84%2.18B81.02%5.96B6.32%959M-16.08%1.38B405.56%1.82B364.95%1.8B
Minority interest income 0.00%6M00.00%4M-50.00%1M0.00%1M20.00%6M-200.00%-1M100.00%4M2M-50.00%1M
Net income attributable to the parent company 18.14%7.04B56.25%1.5B4.00%1.43B6.00%1.93B20.85%2.18B81.11%5.96B6.55%960M-16.22%1.37B405.00%1.82B367.10%1.8B
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders 18.14%7.04B56.25%1.5B4.00%1.43B6.00%1.93B20.85%2.18B81.11%5.96B6.55%960M-16.22%1.37B405.00%1.82B367.10%1.8B
Basic earnings per share 18.23%2.2756.45%0.4853.37%0.465.98%0.6221.55%0.70581.13%1.926.90%0.31-16.04%0.445408.70%0.585364.00%0.58
Diluted earnings per share 18.11%2.2554.84%0.483.41%0.4555.98%0.6220.69%0.780.57%1.9056.90%0.31-16.19%0.44408.70%0.585364.00%0.58
Dividend per share 2.41%1.48507.53%0.500.00%0.9850.00%1.4500.00%0.46500.00%0.985
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+6.41%
MARA Holdings
MARA
+6.02%
Tesla
TSLA
+3.91%
Coinbase
COIN
+3.48%
Apple
AAPL
+1.91%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday+1.06%